These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Emphysematous Pyelonephritis in Type 2 Diabetes - Clinical Profile and Management. Bhat SK; Srivastava A; Ansari NA; Rai P; Singh RP; Srivastava R; Roy AK; Fatima J Saudi J Kidney Dis Transpl; 2021; 32(6):1646-1654. PubMed ID: 35946277 [TBL] [Abstract][Full Text] [Related]
5. Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11-year prospective study at a tertiary referral centre. Krishnamoorthy S; Zumla A; Sekar H; Muneer A; Thiruvengadam G; Kumaresan N BJU Int; 2021 Apr; 127(4):418-427. PubMed ID: 32871043 [TBL] [Abstract][Full Text] [Related]
6. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. Kapoor R; Muruganandham K; Gulia AK; Singla M; Agrawal S; Mandhani A; Ansari MS; Srivastava A BJU Int; 2010 Apr; 105(7):986-9. PubMed ID: 19930181 [TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis. Khaira A; Gupta A; Rana DS; Gupta A; Bhalla A; Khullar D Int Urol Nephrol; 2009 Dec; 41(4):959-66. PubMed ID: 19404766 [TBL] [Abstract][Full Text] [Related]
8. Could platelet to leucocytic count ratio (PLR) predict sepsis and clinical outcomes in patients with emphysematous pyelonephritis? Elbaset MA; Zahran MH; Hashem A; Ghobrial FK; Elrefaie E; Badawy M; Shokeir AA; Ibrahim MA J Infect Chemother; 2019 Oct; 25(10):791-796. PubMed ID: 31103341 [TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis. Desai R; Batura D Int Urol Nephrol; 2022 Apr; 54(4):717-736. PubMed ID: 35103928 [TBL] [Abstract][Full Text] [Related]
11. Emphysematous pyelonephritis: multicenter clinical and therapeutic experience in Mexico. Olvera-Posada D; Armengod-Fischer G; Vázquez-Lavista LG; Maldonado-Ávila M; Rosas-Nava E; Manzanilla-García H; Castillejos-Molina RA; Méndez-Probst CE; Sotomayor M; Feria-Bernal G; Rodríguez-Covarrubias F Urology; 2014 Jun; 83(6):1280-4. PubMed ID: 24726310 [TBL] [Abstract][Full Text] [Related]
13. Predictors of outcome in emphysematous pyelonephritis. Wan YL; Lo SK; Bullard MJ; Chang PL; Lee TY J Urol; 1998 Feb; 159(2):369-73. PubMed ID: 9649241 [TBL] [Abstract][Full Text] [Related]
15. Emphysematous pyelonephritis: an 8-year retrospective review across four acute hospitals. Tsu JH; Chan CK; Chu RW; Law IC; Kong CK; Liu PL; Cheung FK; Yiu MK Asian J Surg; 2013 Jul; 36(3):121-5. PubMed ID: 23810162 [TBL] [Abstract][Full Text] [Related]
16. Emphysematous pyelonephritis. A report of two cases. Spagnola AM Am J Med; 1978 May; 64(5):840-4. PubMed ID: 645748 [TBL] [Abstract][Full Text] [Related]
17. Emphysematous pyelonephritis: a 15-year experience with 20 cases. Shokeir AA; El-Azab M; Mohsen T; El-Diasty T Urology; 1997 Mar; 49(3):343-6. PubMed ID: 9123695 [TBL] [Abstract][Full Text] [Related]
18. Deriving a management algorithm for emphysematous pyelonephritis: Can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy? Boakes E; Batura D Int Urol Nephrol; 2017 Dec; 49(12):2127-2136. PubMed ID: 28933020 [TBL] [Abstract][Full Text] [Related]
19. [Emphysematous pyelonephritis. Epidemiological, clinical, biological, bacteriological, radiological, therapeutic and prognostic features. Retrospective study of 30 cases]. Cherif M; Kerkeni W; Bouzouita A; Selmi MS; Derouiche A; Ben Slama MR; Chebil M Tunis Med; 2012 Oct; 90(10):725-9. PubMed ID: 23096514 [TBL] [Abstract][Full Text] [Related]
20. [Results of conservative management of emphysematous pyelonephritis]. Saadi A; Ayed H; Bouzouita A; Cherif M; Kerkeni W; Selmi S; Ben Slama R; Derouiche A; Chebil M Nephrol Ther; 2016 Dec; 12(7):508-515. PubMed ID: 27789323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]